Search
Search Results
##search.searchResults.foundPlural##
-
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2121PDF: 1404HTML: 691 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2424PDF: 779HTML: 1728 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
822PDF: 485HTML: 1292 -
-
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2003PDF: 808HTML: 204 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
713PDF: 463HTML: 6259 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4010PDF: 1137HTML: 1925Fig.1: 212Fig. 2: 105Table 1: 198Table2: 214Table 3: 195 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2125PDF: 1447HTML: 258 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1550PDF: 837HTML: 1028Picture 1: 162 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3160PDF: 766HTML: 2933Figure 1a and 1b: 144Figure 2: 154Figure 3: 173Figure 4: 154Figure 5: 159Tables 1-5: 150 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1301PDF: 756HTML: 491 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3721PDF: 1639HTML: 11545Figures Haase: 191 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4049PDF: 1922HTML: 1754 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1343HTML: 382PDF: 809 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
967PDF: 686HTML: 216 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2153PDF: 1187HTML: 3699 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12308PDF: 1665HTML: 4152Cover letter: 193Figure 1: 199 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2324PDF: 890HTML: 405 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4278PDF: 1474HTML: 1538Untitled: 219 -
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
955PDF: 605HTML: 217 -
HEMOGLOBIN ANALYSIS IN THE FIRST YEAR OF LIFE
3435PDF: 1018HTML: 3021 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
809PDF: 536HTML: 4009 -
PROPHYLAXIS OF MALARIA
2976PDF: 1012HTML: 17784Figures SChwartz: 157 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2059PDF: 1652HTML: 360 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1610PDF: 1163HTML: 191 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1742PDF: 813HTML: 220







